Award recordCONTRACT

COSETTE PHARMACEUTICALS, INC.

PIID 36C26025F0239· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2025· $3,365 net obligations· UEI HDQFPZ3SBV24· NJ

Description

VYLEESI 1.75MG/0.3ML AUTOINJECTOR

First action · last action
2025-04-29 · 2025-08-22
Transactions
2
First transaction's obligation
$6,056
Base + all options value (sum of deltas)
$3,365
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0191
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$6,056$0Base award · 2025-04-29 · this action $6,056 · running total $6,056Modification P00001 · 2025-08-22 · this action -$2,692 · running total $3,365
  • Base2025-04-29+$6,056= $6,056
  • Mod P000012025-08-22-$2,692= $3,365
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2025-04-29+$6,056$6,056VYLEESI 1.75MG/0.3ML AUTOINJECTOR
Mod P00001· FUNDING ONLY ACTION2025-08-22−$2,692$3,365VYLEESI 1.75MG/0.3ML AUTOINJECTOR

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI HDQFPZ3SBV24)

AwardOffice · PSC / listingNet obligationsFY
36C25026F0668250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$10,398FY2026
36C26026F0379260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$3,466FY2026
36C24526N0726245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$6,932FY2026
36C25926P0553NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$3,439FY2026
36C24526N0685245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$6,932FY2026
36C25926P0526NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$1,146FY2026

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026
36C26026F0294BIOCRYST PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$151,465FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26025F0239_3600_36F79720D0191_3600 · retrieved 2026-09-26.